In the last year, Chinese technology stocks slumped as the country’s economy worsened. That changed when U.S. tariffs against China fell to just 10%. PDD (PDD), which owns Temu, is leading the rally.
PDD stock bottomed at below $100 in Dec. 2024, closing at $131.34 last Friday. Scion Asset Management added PDD stock in Q4/2024. In addition, the firm added companies like Estee Lauder (EL), HCA Healthcare (HCA), and Shift4 Payments (FOUR) to its holdings.
MercadoLibre (MELI) jumped by 7.09% on Feb. 21. The e-commerce firm posted Q4 GAAP earnings per share of $12.61. It beat analyst estimates by over $5.00 per share. Revenue rose by 37.4% Y/Y to $6.06 billion. The firm said it is “seeing tangible evidence of the power of the ecosystem as each part of it strengthens engagement in the others.”
MELI stock is an outsized winner that investors should hold.
In the vaccine market, Moderna (MRNA), a short-sellers favorite with a short interest of 10.55%, likely bottomed. In China, researchers identified a new bat coronavirus that potentially transferred to humans. HKU5-CoV-2 uses the ACE2 receptor as a means of infection. Investors should consider selling into the rally of MRNA stock. Vaccine sales for the virus are unlikely to grow at levels seen during the panic. In addition, BioNTech (BNTX) and Novavax (NVAX) are unattractive investments at this time for the same reason.
creator solana token
